Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
In the article by Lee et al. (June 19 issue),
1
the reported elevation in levels of serum creatinine and low-density lipoprotein (LDL) cholesterol in a proportion of patients in the tofacitinib group may be a cause for concern, given the prevalence of adverse renal and cardiovascular outcomes among patients with rheumatoid a...
Alternative Titles
Full title
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1563981011
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1563981011
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1408607
